UCLA SURGEONS IDENTIFY MOLECULAR PATHWAY THAT MAY HELP TARGET FUTURE THERAPIES AGAINST TUMOR ANGIOGENESIS Study provides a new look at molecular contributors to angiogenesis CHICAGO—Researchers at the University of California […]
Metformin reduces the growth of pancreatic cancer
Metformin (Glucophag) reduces the growth of pancreatic cancer Investigators supported by the Hirshberg Foundation, including dr Kisfalvi (a recipient of a seed grant from the Foundation), Dr. Eibl (Hirshberg […]
Risk of Pancreatic Cancer Linked to Variation in Gene that Determines Blood Type
From: http://www.cancer.gov/newscenter/pressreleases/ABOvariantPanScan Risk of Pancreatic Cancer Linked to Variation in Gene that Determines Blood Type Common variants of the gene that determines human blood type are associated with an increased […]
Phase One Clinical Trial
The Macrobead Phase One Clinical Trial 1/4/2008 Click for Summary
Scientific Discovery at UCLA for Pancreatic Cancer
Scientific Discovery Supported by the Hirshberg Foundation, at UCLA Ductal adenocarcinoma of the pancreas, which comprises 90% of all human pancreatic cancers, is a devastating disease, with overall 5-year survival […]
GenVec Announces Efficacy Update in Phase II/III Clinical Trial
Press Release